相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres
Monika Kohli et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2017)
Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report
Yuki Awanami et al.
BMC NEPHROLOGY (2017)
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia
Mary E. Haas et al.
CIRCULATION (2016)
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
William G. Herrington et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study
Eri Muso et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Plasma PCSK9 in Nephrotic Syndrome and in Peritoneal Dialysis: A Cross-sectional Study
Kyubok Jin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome
Shuman Liu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Chapter 2: General principles in the management of glomerular disease
Kidney International Supplements (2012)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9
Holly E. Careskey et al.
JOURNAL OF LIPID RESEARCH (2008)
Atorvastatin-induced early-onset rhabdomyolysis in a patient with nephrotic syndrome
Jimmy Jose et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
分享论文
